SWEDISH ORPHAN BIOVITRUM AB revenue for the last year amounted to 26.03 B SEK, the most of which — 16.43 B SEK — came from its highest performing source at the moment, Haematology, the year earlier bringing 13.37 B SEK. The greatest contribution to the revenue figure was made by Europe — last year it brought SWEDISH ORPHAN BIOVITRUM AB 9.04 B SEK, and the year before that — 7.85 B SEK.